Pharmacodynamics of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model of Infection

The pharmacodynamics of gemifloxacin against Streptococcus pneumoniae were investigated in a dilutional pharmacodynamic model of infection. Dose fractionation was used to simulate concentrations of gemifloxacin in human serum associated with 640 mg every 48 h (one dose), 320 mg every 24 h (two doses...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: MacGowan, Alasdair P., Rogers, Chris A., Holt, H. Alan, Wootton, Mandy, Bowker, Karen E.
Format: Članak
Jezik:en
Izdano: American Society for Microbiology 2001
Teme:
Experimental Therapeutics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC90752/
https://ncbi.nlm.nih.gov/pubmed/11557490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.10.2916-2921.2001
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC90752/
https://ncbi.nlm.nih.gov/pubmed/11557490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.10.2916-2921.2001

Similar Items